Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Kamakura
Clinical trial register · Japan

Clinical Trials in Kamakura, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Kamakura

30 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Novartis Pharmaceuticals
Phase 2
180
Kasugai, Matsudo, Kamakura, Matsubara
2026-09-18
Recruiting
Bristol-Myers Squibb
Phase 3
750
Toyohashi, Funabashi, Tōon, Sapporo, Nishinomiya, Kanazawa, Kamakura, Yokohama
2026-03-12
Recruiting
Sanofi
Phase 3
751
Kamakura, Nishinomiya, Tsu
2026-01-22
Recruiting
Sanofi
Phase 3
751
Bunkyō City, Chikushino-shi, Hachiōji, Kagoshima, Kamakura, Kashiwa, Kobe, Kōriyama
2026-01-16
Active, closed
A Clinical Evaluation of AMJ-401
NCT07373353Ischemic Heart Disease (IHD)
Abbott Medical Devices
Not applicable
50
Toyoake, Tokyo, Kitakyushu, Shiwa-gun, Kamakura, Kawasaki, Miyazaki, Sakai
2025-12-17
Recruiting
Eli Lilly and Company
Phase 3
1,035
Chigasaki, Chūōku, Kamakura, Kasuya-gun, Kawaguchi, Kita-ku, Mihama-ku,Chiba City, Naha
2025-12-15
Recruiting
Eli Lilly and Company
Phase 2
252
Fukuoka, Kamakura, Kashiwa, Osaka, Sakura, Sapporo
2025-11-10
Recruiting
Sanofi
Phase 3
980
Asahikawa, Bunkyō City, Chikushino-shi, Chūō, Fukuoka, Kagoshima, Kamakura, Kanazawa
2025-10-08
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Chikushino-shi, Kitakyushu, Kamakura, Sagamihara, Bunkyo Ku
2025-10-03
Recruiting
Bristol-Myers Squibb
Phase 3
586
Inage, Matsudo, Hiroshima, Kita-gun, Kamakura, Kawasaki, Ina, Kashiwazaki
2025-07-21
Active, closed
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033Primary Myelofibrosis, Myeloproliferative Neoplasm
PharmaEssentia
Phase 3
160
Kamogawa, Matsuyama, Hiroshima, Morioka, Kamakura, Tsu, Miyazaki, Hirakata
2025-07-18
Recruiting
Novartis Pharmaceuticals
Phase 3
940
Nagoya, Sapporo, Kobe, Kamakura, Yokohama, Kumamoto, Chuo Ku, Chiba
2025-07-01
Recruiting
Osaka University
Not applicable
450
Matsudo, Urayasu, Kitakyushu, Kurume, Nishinomiya, Isehara, Kamakura, Kawasaki
2025-06-01
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
Fukuoka, Hyōgo, Ibaraki, Kamakura, Meguro City, Mitaka, Miyagi, Toyota
2025-05-15
Recruiting
Prevail Global Study
NCT06535854Coronary Artery Disease
Medtronic Vascular
Not applicable
1,205
Kitakyushu, Kamakura, Yokohama, Sendai, tabashi City
2025-02-24
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
Alexion Pharmaceuticals, Inc.
Phase 3
584
Bunkyō City, Chiba, Fukuoka, Kamakura, Kasugai-shi, Kitakyushu-shi, Kobe, Matsumoto-shi
2024-03-29
Active, closed
Study of Tamibarotene in Patients With ADPKD
NCT06289998Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Rege Nephro Co., Ltd.
Phase 2
70
Kurume, Sapporo, Kamakura, Kawasaki, Kyoto, Bunkyo-ku, Minato-ku, Shinjukuku
2023-12-22
Active, closed
Otsuka Medical Devices Co., Ltd. Japan
Not applicable
24
Urayasu, Fukuoka, Kitakyushu, Kamakura, Osaka City, Osaka
2023-03-10
Active, closed
Bristol-Myers Squibb
Phase 3
606
Nagoya, Kashiwa, Kitakyushu-shi, Sapporo, Higashiibaraki, Kanazawa, Shiwa-gun Yahaba-cho, Kamakura
2023-01-10
Recruiting
Celgene
Phase 3
810
Kashiwa, Kitakyushu-shi, Sapporo, Higashiibaraki, Shiwa-gun Yahaba-cho, Kamakura, Iruma, Koshigaya
2022-09-20
Active, closed
Sanofi
Phase 3
531
Nagoya, Kamogawa, Higashiibaraki, Yahaba, Kamakura, Okayama, Kyoto, Osaka
2022-06-23
Active, closed
Takeda
Phase 3
56
Toyota, Hirosaki, Kashiwa, Sakura, Chikushino-shi, Sapporo, Nishinomiya, Kamakura
2021-06-04
Active, closed
Celgene
Phase 3
313
Nagasaki, Sayama, Bunkyo-ku, Chūō, Aomori, Bunkyō City, Isehara City, Kanagawa, Kamakura
2021-02-25
Active, closed
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries
NCT04192747Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Stenosis
Elixir Medical Corporation
Not applicable
445
Kitakyushu, Kurume, Sapporo, Tsuchiura, Kagoshima, Kamakura, Kawasaki-shi, Yokohama
2020-12-16
Active, closed
Amplatzer Amulet LAAO vs. NOAC
NCT04226547Atrial Fibrillation, Stroke, Bleeding
DrugNOAC
Abbott Medical Devices
Not applicable
2,650
Toyohashi, Chiba, Kitakyushu, Tsukuba, Kamakura, Sendai, Kurashiki-shi, Meguro-ku
2020-07-07
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Aichi, Aomori, Chiba, Fukuoka, Hokkaido, Kamakura, Miyazaki, Okayama
2019-12-16
Active, closed
Medtronic Cardiovascular
Not applicable
2,223
Kitakyushu, Sapporo, Tokyo, Kamakura, Sendai, Suita, Fuchū
2016-03
Recruiting
Medtronic
Observational
20,000
Ageo, Bunkyō City, Gifu, Hidaka, Hiroshima, Kagoshima, Kamakura, Kawasaki
1983-01
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-japan/city/kamakura

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Kamakura.

How many clinical trials are recruiting in Kamakura?

16 of the 30 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kamakura), 30 studies
PhaseStudiesRecruitingShare
Phase 316953.3%
Not applicable7223.3%
Phase 24213.3%
Observational113.3%
Phase 1/2113.3%
Phase 2/3113.3%

Most active sponsors

Lead sponsors with the most studies (Kamakura)
Lead sponsorStudiesRecruiting
Sanofi53
Bristol-Myers Squibb32
Novartis Pharmaceuticals33
Abbott Medical Devices20
Celgene21
Eli Lilly and Company22
Alexion Pharmaceuticals, Inc.10
Corxel Pharmaceuticals11
Elixir Medical Corporation10
GlaxoSmithKline10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.